Skip to main content
SpringerLink
Log in

Physiologic Assessment of COPD

  • Chapter
  • First Online:
COPD

Part of the book series: Respiratory Medicine ((RM))

  • 5522 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Global Initiative for Chronic Obstructive Lung Disease (2006) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; Available at: www.goldcopd.com

  2. Badgett RG, Tanaka DJ, Hunt DK et al (1993) Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med 94(2):188–196

    Article  CAS  PubMed  Google Scholar 

  3. Thurlbeck WM, Simon G (1978) Radiographic appearance of the chest in emphysema. Am J Roentgenol 130(3):429–440

    CAS  Google Scholar 

  4. Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968

    Article  CAS  PubMed  Google Scholar 

  5. Calverley PMA, Pearson MG (2003) Clinical and laboratory assessment. In: Calverley PMA, MacNee W, Rennard SI, Pride NB (eds) Chronic obstructive pulmonary disease, 2nd edn. Arnold, London, pp 282–309

    Google Scholar 

  6. Hardie JA, Buist AS, Vollmer WM et al (2002 November 1) Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 20(5):1117–1122

    Article  CAS  PubMed  Google Scholar 

  7. Akpinar-Elci M, Fedan KB, Enright PL (2006 February 1) FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 27(2):374–377

    Article  CAS  PubMed  Google Scholar 

  8. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W (2006 February 1) Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J 27(2):378–383

    Article  CAS  PubMed  Google Scholar 

  9. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W (2005 May) FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 127(5):1560–1564

    Article  PubMed  Google Scholar 

  10. Hansen JE, Sun XG, Wasserman K (2006 June) Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction? Eur Respir J 27(6):1244–1250

    Article  CAS  PubMed  Google Scholar 

  11. Zielinski J, Bednarek M, Gorecka D et al (2006 April 1) Increasing COPD awareness. Eur Respir J 27(4):833–852

    Article  CAS  PubMed  Google Scholar 

  12. Zielinski J, Bednarek M (2001 March 1) Early detection of COPD in a high-risk population using spirometric screening. Chest 119(3):731–736

    Article  CAS  PubMed  Google Scholar 

  13. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O (2004) Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 54(500):201–206

    PubMed  Google Scholar 

  14. Gorecka D, Bednarek M, Nowinski A et al (2003 June 1) Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 123(6):1916–1923

    Article  PubMed  Google Scholar 

  15. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L (2006) Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 28(5):945–952

    Article  CAS  PubMed  Google Scholar 

  16. Wolkove N, Dajczman E, Colacone A, Kreisman H (1989 December) The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 96(6):1247–1251

    Article  CAS  PubMed  Google Scholar 

  17. Jones PW, Baveystock CM, Littlejohns P (1989) Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis 140(6):1538–1543

    CAS  PubMed  Google Scholar 

  18. Sin DD, Jones RL, Mannino DM, Paul Man SF (2004 August 15) Forced expiratory volume in 1 second and physical activity in the general population. Am J Med 117(4):270–273

    Article  PubMed  Google Scholar 

  19. LoRusso TJ, Belman MJ, Elashoff JD, Koerner SK (1993 December 1) Prediction of maximal exercise capacity in obstructive and restrictive pulmonary disease. Chest 104(6):1748–1754

    Article  CAS  PubMed  Google Scholar 

  20. Hay JG, Stone P, Carter J et al (1992 June) Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 5(6):659–664

    CAS  PubMed  Google Scholar 

  21. Bauerle O, Chrusch CA, Younes M (1998 January) Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 157(1):57–68

    CAS  PubMed  Google Scholar 

  22. Carlson DJ, Ries AL, Kaplan RM (1991 August) Prediction of maximum exercise tolerance in patients with COPD. Chest 100(2):307–311

    Article  CAS  PubMed  Google Scholar 

  23. O’Donnell DE, Lam M, Webb KA (1998 November 1) Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158(5):1557–1565

    PubMed  Google Scholar 

  24. Chrystyn H, Mulley BA, Peake MD (1988 December 10) Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ 297(6662):1506–1510

    Article  CAS  PubMed  Google Scholar 

  25. Belman MJ, Botnick WC, Shin JW (1996 March 1) Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153(3):967–975

    CAS  PubMed  Google Scholar 

  26. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC (2003) Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58(5):388–393

    Article  CAS  PubMed  Google Scholar 

  27. Anthonisen NR, Wright EC, Hodgkin JE (1986) Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133(1):14–20

    CAS  PubMed  Google Scholar 

  28. Stavem K, Aaser E, Sandvik L et al (2005 April 1) Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 25(4):618–625

    Article  CAS  PubMed  Google Scholar 

  29. Hyatt RE (1983 July 1) Expiratory flow limitation. J Appl Physiol 55(1):1–7

    CAS  PubMed  Google Scholar 

  30. Dawson SV, Elliott EA (1977 September) Wave-speed limitation on expiratory flow-a unifying concept. J Appl Physiol 43(3):498–515

    CAS  PubMed  Google Scholar 

  31. Eltayara L, Becklake MR, Volta CA, Milic-Emili J (1996 December 1) Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154(6):1726–1734

    CAS  PubMed  Google Scholar 

  32. Johnson BD, Weisman IM, Zeballos RJ, Beck KC (1999 August) Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest 116(2):488–503

    Article  CAS  PubMed  Google Scholar 

  33. Johnson BD, Reddan WG, Pegelow DF, Seow KC, Dempsey JA (1991 May) Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am Rev Respir Dis 143(5 Pt 1):960–967

    CAS  PubMed  Google Scholar 

  34. Calverley PMA, Koulouris NG (2005 January 1) Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 25(1):186–199

    Article  CAS  PubMed  Google Scholar 

  35. Koulouris NG, Valta P, Lavoie A et al (1995 February 1) A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 8(2):306–313

    Article  CAS  PubMed  Google Scholar 

  36. Ninane V, Leduc D, Kafi S et al (2001 May 1) Detection of expiratory flow limitation by manual compression of the abdominal wall. Am J Respir Crit Care Med 163(6):1326–1330

    CAS  PubMed  Google Scholar 

  37. Mead J, Whittenberger JL (1953) Physical properties of human lungs measured during spontaneous respiration. J Appl Physiol 5(12):779–796

    Google Scholar 

  38. Dellaca RL, Santus P, Aliverti A et al (2004 February 1) Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J 23(2):232–240

    CAS  PubMed  Google Scholar 

  39. Detels R, Tashkin DP, Simmons MS et al (1982 November 1) The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function. Chest 82(5):630–638

    Article  CAS  PubMed  Google Scholar 

  40. Hansen EF, Vestbo J, Phanareth K, Kok-Jensen A, Dirksen A (2001 March 1) Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163(3):690–693

    CAS  PubMed  Google Scholar 

  41. Vinegar A, Sinnett EE, Leith DE (1979 May) Dynamic mechanisms determine functional residual capacity in mice, Mus musculus. J Appl Physiol 46(5):867–871

    CAS  PubMed  Google Scholar 

  42. Gelb AF, Gutierrez CA, Weisman IM et al (2004 December) Simplified detection of dynamic hyperinflation. Chest 126(6):1855–1860

    Article  PubMed  Google Scholar 

  43. Parker CM, Voduc N, Aaron SD, Webb KA, O’Donnell DE (2005 1) Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 26(3):420–428

    Article  CAS  PubMed  Google Scholar 

  44. Stevenson NJ, Walker PP, Costello RW, Calverley PM (2005 December 15) Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172(12):1510–1516

    Article  PubMed  Google Scholar 

  45. O’Donnell DE (2006 April) Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3(2):180–184

    Article  PubMed  Google Scholar 

  46. O’Donnell DE, Revill SM, Webb KA (2001 ) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(5):770–777

    PubMed  Google Scholar 

  47. Pare PD, Wiggs BJ, Coppin CA (1983) Errors in the measurement of total lung capacity in chronic obstructive lung disease. Thorax 38(6):468–471

    Article  CAS  PubMed  Google Scholar 

  48. Bohadana AB, Peslin R, Hannhart B, Teculescu D (1982 March) Influence of panting frequency on plethysmographic measurements of thoracic gas volume. J Appl Physiol 52(3):739–747

    CAS  PubMed  Google Scholar 

  49. Brown R, Slutsky AS (1984 December) Frequency dependence of plethysmographic measurement of thoracic gas volume. J Appl Physiol 57(6):1865–1871

    CAS  PubMed  Google Scholar 

  50. Tantucci C, Duguet A, Similowski T et al (1998 October 1) Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 12(4):799–804

    Article  CAS  PubMed  Google Scholar 

  51. Diaz O, Villafranca C, Ghezzo H et al (2000 August 1) Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 16(2):269–275

    Article  CAS  PubMed  Google Scholar 

  52. Boni E, Corda L, Franchini D et al (2002 June 1) Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax 57(6):528–532

    Article  CAS  PubMed  Google Scholar 

  53. Casanova C, Cote C, de Torres JP et al (2005 March 15) Inspiratory-to-total lung capacity ratio predicts mortality in patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 171(6):591–597

    Article  PubMed  Google Scholar 

  54. O’Donnell DE, Travers J, Webb KA, He Z, Lam Y-M, Hamilton A, Kesten S, Maltais F, Magnussen H (2009) Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 34(4):866–874. doi:doi:10.1183/09031936.00168708, published online 12 March 2009

    Article  PubMed  Google Scholar 

  55. O’Donnell DE, Fluge T, Gerken F et al (2004 June 1) Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23(6):832–840

    Article  PubMed  CAS  Google Scholar 

  56. Maltais F, Hamilton A, Marciniuk D et al (2005) Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128(3):1168–1178

    Article  CAS  PubMed  Google Scholar 

  57. Simon G (1971) Principles of chest x-ray diagnosis, 3rd edn. Butterworth, London

    Google Scholar 

  58. Simon G, Pride NB, Jones NL, Raimondi AC (1973 January) Relation between abnormalities in the chest radiograph and changes in pulmonary function in chronic bronchitis and emphysema. Thorax 28(1):15–23

    Article  CAS  PubMed  Google Scholar 

  59. Burki NK, Krumpelman JL (1980 February) Correlation of pulmonary function with the chest roentgenogram in chronic airway obstruction. Am Rev Respir Dis 121(2):217–223

    CAS  PubMed  Google Scholar 

  60. Nakano Y, Muro S, Sakai H et al (2000 September) Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 162(3 Pt 1):1102–1108

    CAS  PubMed  Google Scholar 

  61. de Jong PA, Muller NL, Pare PD, Coxson HO (2005 July) Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 26(1):140–152

    Article  PubMed  Google Scholar 

  62. Park KJ, Bergin CJ, Clausen JL (1999 May 1) Quantitation of emphysema with three-dimensional CT densitometry: Comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 211(2):541–547

    CAS  PubMed  Google Scholar 

  63. Morrison NJ, Abboud RT, Ramadan F et al (1989 May) Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 139(5):1179–1187

    CAS  PubMed  Google Scholar 

  64. Leech JA, Martz L, Liben A, Becklake MR (1985) Diffusing capacity for carbon monoxide. The effects of different derivations of breathhold time and alveolar volume and of carbon monoxide back pressure on calculated results. Am Rev Respir Dis 132(5):1127–1129

    CAS  PubMed  Google Scholar 

  65. Flynn E, O’Driscoll R (2002 July 1) Exercise testing in the consulting room. Chest 122(1):383

    Article  PubMed  Google Scholar 

  66. Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL (2001 July) Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 120(1):88–92

    Article  CAS  PubMed  Google Scholar 

  67. O’Donnell DE, Webb KA (1992 September) Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest 102(3):824–831

    Article  PubMed  Google Scholar 

  68. Anthonisen NR, Lindgren PG, Tashkin DP et al (2005) Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 26(1):45–51

    Article  CAS  PubMed  Google Scholar 

  69. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW (2003 August 1) Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 58(8):659–664

    Article  CAS  PubMed  Google Scholar 

  70. Kerstjens HA, Brand PL, Quanjer PH et al (1993) Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group. Thorax 48(7):722–729

    Article  CAS  PubMed  Google Scholar 

  71. Tobin MJ, Hughes JA, Hutchison DC (1984 August) Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance. Eur J Respir Dis 65(6):441–446

    CAS  PubMed  Google Scholar 

  72. Leitch AG, Hopkin JM, Ellis DA, Merchant S, McHardy GJ (1978 December 1) The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 33(6):711–713

    Article  CAS  PubMed  Google Scholar 

  73. Muir JF, Benhamou D, Cuvelier A et al (2004) FEV1 reversibility does not adequately predict effect of formoterol via AerolizerR in chronic obstructive pulmonary disease. Int J Clin Pract 58(5):457–464

    Article  CAS  PubMed  Google Scholar 

  74. Tashkin D, Kesten S (2003 May 1) Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 123(5):1441–1449

    Article  CAS  PubMed  Google Scholar 

  75. Newton MF, O’Donnell DE, Forkert L (2002 April) Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 121(4):1042–1050

    Article  CAS  PubMed  Google Scholar 

  76. O’Donnell DE, Forkert L, Webb KA (2001 December) Evaluation of bronchodilator responses in patients with “irreversible” emphysema. Eur Respir J 18(6):914–920

    Article  PubMed  Google Scholar 

  77. O’Donnell DE, Lam M, Webb KA (1999 August 1) Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(2):542–549

    PubMed  Google Scholar 

  78. Celli B, ZuWallack R, Wang S, Kesten S (2003 November) Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124(5):1743–1748

    Article  PubMed  Google Scholar 

  79. Olsen CR, Hale FC (1968 August) A method for interpreting acute response to bronchodilators from the spirogram. Am Rev Respir Dis 98(2):301–302

    CAS  PubMed  Google Scholar 

  80. Boggs PB, Bhat KD, Vekovius WA, Debo MS (1982 March) The clinical significance of volume-adjusted maximal mid-expiratory flow (iso-volume FEF25–75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics. Ann Allergy 48(3):139–142

    CAS  PubMed  Google Scholar 

  81. O’Donnell DE, Voduc N, Fitzpatrick M, Webb KA (2004 July 1) Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24(1):86–94

    Article  PubMed  CAS  Google Scholar 

  82. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA (2003 August 1) Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 58(8):654–658

    Article  CAS  PubMed  Google Scholar 

  83. Taube C, Lehnigk B, Paasch K et al (2000 July 1) Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162(1):216–220

    CAS  PubMed  Google Scholar 

  84. Hansen EF, Phanareth K, Laursen LC, Kok-Jensen A, Dirksen A (1999) Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159(4):1267–1271

    CAS  PubMed  Google Scholar 

  85. Ortega F, Montemayor T, Sanchez A, Cabello F, Castillo J (1994 ) Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150(3):747–751

    CAS  PubMed  Google Scholar 

  86. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T (2003 February 15) Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 167(4):544–549

    Article  PubMed  Google Scholar 

  87. Pollock M, Roa J, Benditt J, Celli B (1993 November) Estimation of ventilatory reserve by stair climbing. A study in patients with chronic airflow obstruction. Chest 104(5):1378–1383

    Article  CAS  PubMed  Google Scholar 

  88. McGavin CR, Artvinli M, Naoe H, McHardy GJ (1978 July 22) Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 2(6132):241–243

    Article  CAS  PubMed  Google Scholar 

  89. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR (2004 January 1) The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23(1):28–33

    Article  CAS  PubMed  Google Scholar 

  90. Wu G, Sanderson B, Bittner V (2003 July) The 6-minute walk test: How important is the learning effect? Am Heart J 146(1):129–133

    Article  PubMed  Google Scholar 

  91. Guyatt GH, Pugsley SO, Sullivan MJ et al (1984 November 1) Effect of encouragement on walking test performance. Thorax 39(11):818–822

    Article  CAS  PubMed  Google Scholar 

  92. Knox AJ, Morrison JF, Muers MF (1988 May 1) Reproducibility of walking test results in chronic obstructive airways disease. Thorax 43(5):388–392

    Article  CAS  PubMed  Google Scholar 

  93. Stevens D, Elpern E, Sharma K et al (1999 November) Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med 160(5 Pt 1):1540–1543

    CAS  PubMed  Google Scholar 

  94. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE (1992 December) Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47(12):1019–1024

    Article  CAS  PubMed  Google Scholar 

  95. Singh SJ, Morgan MD, Hardman AE, Rowe C, Bardsley PA (1994 November) Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 7(11):2016–2020

    CAS  PubMed  Google Scholar 

  96. Eaton T, Young P, Nicol K, Kolbe J (2006) The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients. Chron Respir Dis 3(1):3–9

    Article  CAS  PubMed  Google Scholar 

  97. Onorati P, Antonucci R, Valli G et al (2003 May) Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 89(3–4):331–336

    Article  PubMed  Google Scholar 

  98. Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE (1999 March 1) The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 54(3):213–222

    Article  CAS  Google Scholar 

  99. Revill SM, Singh SJ, Morgan MD (2000 August) Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med 94(8):778–783

    Article  CAS  PubMed  Google Scholar 

  100. Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC (2004 September) Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest 126(3):766–773

    Article  PubMed  Google Scholar 

  101. Palange P, Forte S, Onorati P et al (2000 May 1) Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 88(5):1715–1720

    CAS  PubMed  Google Scholar 

  102. O’Donnell DE, Bertley JC, Chau LK, Webb KA (1997 January) Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 155(1):109–115

    PubMed  Google Scholar 

  103. Marin JM, Carrizo SJ, Gascon M et al (2001 May) Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163(6):1395–1399

    CAS  PubMed  Google Scholar 

  104. Puente-Maestu L, de Garcia PJ, Martinez-Abad Y et al (2005 August) Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 128(2):651–656

    Article  PubMed  Google Scholar 

  105. O’Donnell DE, Hamilton AL, Webb KA (2006 October) Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 101(4):1025–1035

    Article  PubMed  Google Scholar 

  106. Sinderby C, Spahija J, Beck J et al (2001 June) Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163(7):1637–1641

    CAS  PubMed  Google Scholar 

  107. Bellemare F, Grassino A (1983 July) Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 55(1 Pt 1):8–15

    CAS  PubMed  Google Scholar 

  108. Stubbing DG, Pengelly LD, Morse JL, Jones NL (1980 September) Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 49(3):511–515

    CAS  PubMed  Google Scholar 

  109. Vogiatzis I, Georgiadou O, Golemati S et al (2005) Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 60(9):723–729

    Article  CAS  PubMed  Google Scholar 

  110. Yan S, Kaminski D, Sliwinski P (1997) Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156(1):55–59

    CAS  PubMed  Google Scholar 

  111. Aliverti A, Stevenson N, Dellaca RL et al (2004 March 1) Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 59(3):210–216

    Article  CAS  PubMed  Google Scholar 

  112. O’Donnell DE, D’Arsigny C, Fitzpatrick M, Webb KA (2002 ) Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 166(5):663–668

    Article  PubMed  Google Scholar 

  113. Ofir D, Laveneziana P, Webb KA, Lam Y-M, O’Donnell DE (2008) Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177(6):622–629

    Article  PubMed  Google Scholar 

  114. He Z, Lam M, Webb K, O’Donnell DE (2005) Ventilatory constraints during exercise in patients with mild COPD (abstract). Am J Respir Crit Care Med 171:A304

    Google Scholar 

  115. Celli BR, Cote CG, Marin JM et al (2004 March 4) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012

    Article  CAS  PubMed  Google Scholar 

  116. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999 December 1) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(6):1856–1861

    CAS  PubMed  Google Scholar 

  117. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM (2000 September) Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94(9):859–867

    Article  CAS  PubMed  Google Scholar 

  118. Marquis K, Debigare R, Lacasse Y et al (2002 5) Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166(6):809–813

    Article  PubMed  Google Scholar 

  119. Swallow EB, Reyes D, Hopkinson NS et al (2007 February 1) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62(2):115–120

    Article  PubMed  Google Scholar 

  120. Weitzenblum E, Hirth C, Ducolone A et al (1981 October 1) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36(10):752–758

    Article  CAS  PubMed  Google Scholar 

  121. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E (1999 January 1) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159(1):158–164

    CAS  PubMed  Google Scholar 

  122. Biernacki W, Flenley DC, Muir AL, Macnee W (1988 December 1) Pulmonary hypertension and right ventricular function in patients with COPD. Chest 94(6):1169–1175

    Article  CAS  PubMed  Google Scholar 

  123. Roberts CM, Bugler JR, Melchor R, Hetzel MR, Spiro SG (1993 April) Value of pulse oximetry in screening for long-term oxygen therapy requirement. Eur Respir J 6(4):559–562

    CAS  PubMed  Google Scholar 

  124. Spence DP, Hay JG, Carter J, Pearson MG, Calverley PM (1993 November 1) Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax 48(11):1145–1150

    Article  CAS  PubMed  Google Scholar 

  125. Martinez FJ, Foster G, Curtis JL et al (2006 June 15) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173(12):1326–1334

    Article  PubMed  Google Scholar 

  126. Ware JH, Dockery DW, Louis TA et al (1990) Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol 132(4):685–700

    CAS  PubMed  Google Scholar 

  127. van Pelt W, Borsboom GJ, Rijcken B et al (1994 May) Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med 149(5):1218–1226

    PubMed  Google Scholar 

  128. Mannino DM, Davis KJ (2006 June 1) Lung function decline and outcomes in an elderly population. Thorax 61(6):472–477

    Article  CAS  PubMed  Google Scholar 

  129. Anthonisen NR, Connett JE, Kiley JP et al (1994 November 16) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272(19):1497–1505

    Article  CAS  PubMed  Google Scholar 

  130. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10):847–852

    Article  CAS  PubMed  Google Scholar 

  131. Kerstjens HA, Rijcken B, Schouten JP, Postma DS (1997 September) Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 52(9):820–827

    Article  CAS  PubMed  Google Scholar 

  132. Oga T, Nishimura K, Tsukino M et al (2007 January) Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 101(1):146–153

    Article  PubMed  Google Scholar 

  133. Rabe KF, Bateman ED, O’Donnell D et al (2005 August 13) Roflumilast–an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 366(9485):563–571

    Article  CAS  PubMed  Google Scholar 

  134. Swanney MP, Jensen RL, Crichton DA et al (2000 September) FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 162(3 Pt 1):917–919

    CAS  PubMed  Google Scholar 

  135. Martinez FJ, de Oca MM, Whyte RI et al (1997 June) Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 155(6):1984–1990

    CAS  PubMed  Google Scholar 

  136. O’Donnell DE, McGuire M, Samis L, Webb KA (1995 December) The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 152(6 Pt 1):2005–2013

    PubMed  Google Scholar 

  137. Leach RM, Davidson AC, Chinn S et al (1992 October) Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax 47(10):781–789

    Article  CAS  PubMed  Google Scholar 

  138. Davidson AC, Leach R, George RJ, Geddes DM (1988 December) Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax 43(12):965–971

    Article  CAS  PubMed  Google Scholar 

  139. Oga T, Nishimura K, Tsukino M et al (2000 June) The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 161(6):1897–1901

    CAS  PubMed  Google Scholar 

  140. Peters MM, Webb KA, O’Donnell DE (2006 July) Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 61(7):559–567

    Article  CAS  PubMed  Google Scholar 

  141. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R (2003 November 1) Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 168(9):1034–1042

    Article  PubMed  Google Scholar 

  142. Palange P, Valli G, Onorati P et al (2004 November) Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 97(5):1637–1642

    Article  CAS  PubMed  Google Scholar 

  143. Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL (2006 October 1) Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174(7):763–771

    Article  PubMed  Google Scholar 

  144. Laude EA, Duffy NC, Baveystock C et al (2006 April 15) The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med 173(8):865–870

    Article  PubMed  Google Scholar 

  145. O’Donnell DE, Sanii R, Giesbrecht G, Younes M (1988 November) Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am Rev Respir Dis 138(5):1185–1191

    PubMed  Google Scholar 

  146. O’Donnell DE, Webb KA, Bertley JC, Chau LK, Conlan AA (1996 July) Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. Chest 110(1):18–27

    Article  PubMed  Google Scholar 

  147. Porszasz J, Emtner M, Goto S et al (2005 October) Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 128(4):2025–2034

    Article  PubMed  Google Scholar 

  148. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S (2005 March) Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127(3):809–817

    Article  CAS  PubMed  Google Scholar 

  149. Cote CG, Celli BR (2005 October 1) Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26(4):630–636

    Article  CAS  PubMed  Google Scholar 

  150. O’Donnell DE, Bain DJ, Webb KA (1997 February 1) Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 155(2):530–535

    PubMed  Google Scholar 

  151. O’Donnell DE, D’Arsigny C, Hollingworth EN, Webb KA (2000) Oxygen reduces dynamic hyperinflation and improves exercise performance in hypoxic patients with COPD. Am J Respir Crit Care Med 161:A753

    Google Scholar 

  152. Laveneziana P, O’Donnell DE (2007). The role of spirometry in evaluating therapeutic responses in advanced COPD. Dis Manage Health Outcomes 15(2): 91–100

    PubMed  Google Scholar 

  153. O’Donnell DE, Ofir D, Laveneziana P (2007). Patterns of cardiopulmonary response to exercise in lung diseases. Eur Respir Mon 40:69–92

    PubMed  Google Scholar 

  154. O’Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD: J of COPD 3(4):219–232

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Respiratory Investigation Unit, Department of Medicine, Queen’s University and Kingston General Hospital, Kingston, Canada

    Justin Travers, Pierantonio Laveneziana & Denis E. O’Donnell

Authors
  1. Justin Travers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierantonio Laveneziana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denis E. O’Donnell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Section of Pulmonary and Critical Care M, Baylor College of Medicine, 1504 Taub Loop, Houston, 77030, Texas, USA

    Nicola A. Hanania

  2. Michael E. DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd., Houston, 77030, Texas, USA

    Amir Sharafkhaneh

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Travers, J., Laveneziana, P., O’Donnell, D.E. (2011). Physiologic Assessment of COPD. In: Hanania, N., Sharafkhaneh, A. (eds) COPD. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-357-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-357-8_3

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-949-9

  • Online ISBN: 978-1-59745-357-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation